Corona Immunitas

Corona Immunitas completed its final two rounds of population-based seroprevalence studies in 2022, significantly shaping Switzerland's vaccination strategy in the fall of that year. Led by Murielle Bochud, the prisoner study conducted at Unisanté in Vaud remained ongoing in 2023, with results scheduled for publication in 2024. Other Corona Immunitas studies, such as the Zurich Coronavirus and Vaccination Cohort studies will conclude in 2024. Data management and curation for Corona Immunitas are ongoing, with data accessible upon request and approval from the steering committee. The consortium continues to analyze the extensive databases in 2023, with ongoing research expected to yield publications in 2024 and beyond.

Find out more about corona immunitas on the SSPH+ science in a minute YouTube channel.